Who Owns SVA?

Sinovac Biotech Ltd. — Institutional Ownership & 13F Holdings

$6.47

+0.00 (+0.00%)

Market Cap

$464.9M

Shares Outstanding

71,860,700

Institutional Holders

3

Total Inst. Value

$334.0M

% of Float Held

17.6%

QoQ Holder Change

-20

Institutional data as of Q1 2025

New Positions

2

Closed Positions

2

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ORBIMED ADVISORS LLC$334.0M2,718,735
2Neumann Advisory Hong Kong LtdNew$2K315,586
3Financial Gravity Asset Management, Inc.New$031

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold SVA?

As of Q1 2025, 3 institutional investors report holding SVA (Sinovac Biotech Ltd.) in their 13F filings.

What percentage of Sinovac Biotech Ltd. is owned by institutions?

Institutional investors hold approximately 17.6% of Sinovac Biotech Ltd.'s float as reported in SEC 13F filings.

Which hedge fund owns the most SVA?

The largest institutional holder of SVA is ORBIMED ADVISORS LLC with $334.0M in shares.

Are institutions buying or selling SVA?

This quarter, 2 institutions opened new positions in SVA and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.